Medication info
Elkadin Tablet (L-Carnitine)

Elkadin Tablet (L-Carnitine)

OTC medicationTabletOral
Ingredient · strength
L-Carnitine›330mg / 1 tablet
Manufacturer / importer
Korea Pavis Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
90 tablets/box [10 tablets/PTP*9]
Approval status
Active

MFDS item code 202009428 · Notified 2020.12.31

Summary

Main use
Treatment of carnitine deficiency and myocardial metabolic disorders due to ischemic heart disease
Who takes it
Adults
Adult dose
Adults: Administer 2~3g of L-carnitine per day orally in 2~3 divided doses. Adjust the dose as appropriate according to age and symptoms.

Ingredients

Manufacturer
Korea Pavis Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of carnitine deficiency and myocardial metabolic disorders due to ischemic heart disease

  • Primary carnitine deficiency
  • secondary carnitine deficiency
  • angina
  • acute myocardial infarction
View approved original text

This medication is used to treat primary and secondary carnitine deficiency. It is also effective in treating myocardial metabolic disorders caused by ischemic heart disease, such as angina and acute myocardial infarction. Therefore, it is used in the treatment of various diseases related to heart function improvement.

How to take

Adult dose

Adults: Administer 2~3g of L-carnitine per day orally in 2~3 divided doses. Adjust the dose as appropriate according to age and symptoms.

Precautions

This medicine should not be used in patients who are hypersensitive to it. Temporary nausea or vomiting, abdominal pain, diarrhea, and changes in body odor may occur upon administration. Some patients taking this medication may experience rashes, hives, or facial swelling. Caution should be exercised as mild myasthenia (muscle weakness) can occur in patients with uremic syndrome when taking this medication. Pregnant women or women who could become pregnant should use this medication only if it is determined that the benefits of treatment outweigh the risks, as its safety has not been fully confirmed. Breastfeeding women should carefully decide whether to take this medication as it may be passed into breast milk.

Side effects

  • Temporary areas
  • vomiting
  • abdominal pain
  • diarrhea
  • body odor
  • rash
  • hives
  • facial swelling
  • myasthenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container that can safely protect it from air and moisture, preferably at room temperature between 1 to 30 degrees Celsius. By storing it this way, the medication's efficacy can be maintained for a long time and deterioration can be prevented.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

90 tablets/box [10 tablets/PTP*9]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

  • QI'm taking medication for angina; can I take this together?

    This medication is approved for metabolic disorders of the myocardium due to ischemic heart diseases such as carnitine deficiency, angina, and acute myocardial infarction. If you are being treated for heart disease, please discuss the need for and the dosage of this medication with your physician.

    Answers 1 · 2026.09.14

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.